{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:23:14Z","timestamp":1789564994485,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,21]],"date-time":"2024-10-21T00:00:00Z","timestamp":1729468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.pnpbp.2024.111177","type":"journal-article","created":{"date-parts":[[2024,10,20]],"date-time":"2024-10-20T18:37:40Z","timestamp":1729449460000},"page":"111177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Psychedelic-related deaths in England, Wales and Northern Ireland (1997\u20132022)"],"prefix":"10.1016","volume":"136","author":[{"given":"Emma I.","family":"Kopra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenni","family":"Penttinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Rucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline S.","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111177_bb0005","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1089\/neur.2023.0022","article-title":"Persons with spinal cord injury report peripherally dominant serotonin-like syndrome after use of serotonergic psychedelics","volume":"4","author":"Abrams","year":"2023","journal-title":"Neurotr. Reports"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0010","series-title":"Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects","author":"Aday","year":"2021"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0015","first-page":"150","article-title":"Psychedelic commercialization: a wide-spanning overview of the emerging psychedelic industry","volume":"1","author":"Aday","year":"2023","journal-title":"Psych. Med."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0020","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2005.04.022","article-title":"Nonfatal and fatal DOB (2, 5-dimethoxy-4-bromamphetamine) overdose","volume":"153","author":"Bal\u00edkov\u00e1","year":"2005","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0025","doi-asserted-by":"crossref","DOI":"10.1177\/02698811231224217","article-title":"Interactions between classic psychedelics and serotonergic antidepressants: effects on the acute psychedelic subjective experience, well-being and depressive symptoms from a prospective survey study","author":"Barbut Siva","year":"2024","journal-title":"J. Psychopharmacol. 38, 145-155"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0030","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jat\/bku087","article-title":"A fatal intoxication of 2, 5-dimethoxy-4-chloroamphetamine: a case report","volume":"38","author":"Barnett","year":"2014","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0035","series-title":"Norfolk Woman Took Magic Mushrooms to Ease Pain, Inquest Told","author":"BBC News","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0040","series-title":"Acute Effects of Psilocybin after Escitalopram or Placebo Pretreatment in a Randomized, Double-Blind, Placebo-Controlled, Crossover Study in Healthy Subjects","author":"Becker","year":"2021"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0045","doi-asserted-by":"crossref","first-page":"104242","DOI":"10.1016\/j.ajp.2024.104242","article-title":"Exploring the regulatory framework of psychedelics in the US & Europe","volume":"102","author":"Behera","year":"2024","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0050","doi-asserted-by":"crossref","first-page":"109214","DOI":"10.1016\/j.neuropharm.2022.109214","article-title":"Policy considerations that support equitable access to responsible, accountable, safe, and ethical uses of psychedelic medicines","volume":"219","author":"Belouin","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0055","first-page":"2014","article-title":"25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug","author":"Bersani","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0060","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/ADM.0b013e318279737b","article-title":"Self-inflicted testicular amputation in first lysergic acid diethylamide use","volume":"7","author":"Blacha","year":"2013","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0065","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1177\/02698811221116926","article-title":"Adverse events in clinical treatments with serotonergic psychedelics and MDMA: a mixed-methods systematic review","volume":"36","author":"Breeksema","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0070","doi-asserted-by":"crossref","first-page":"15998","DOI":"10.1038\/s41598-023-41145-x","article-title":"Case analysis of long-term negative psychological responses to psychedelics","volume":"13","author":"Bremler","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0075","doi-asserted-by":"crossref","first-page":"334","DOI":"10.3390\/ph13110334","article-title":"Toxicokinetics and toxicodynamics of ayahuasca alkaloids N, N-dimethyltryptamine (DMT), harmine, harmaline and tetrahydroharmine: clinical and forensic impact","volume":"13","author":"Brito-da-Costa","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0080","series-title":"Drug Checking as a Harm Reduction Tool for Recreational Drug Users: Opportunities and Challenges","author":"Brunt","year":"2017"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0085","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1093\/phe\/phae002","article-title":"Psychedelics in PERIL: The Commercial Determinants of Health, Financial Entanglements and Population Health Ethics","volume":"17","author":"Buchman","year":"2024","journal-title":"Public Health Ethics"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1177\/1941874414528939","article-title":"Hallucinogens causing seizures? A case report of the synthetic amphetamine 2, 5-dimethoxy-4-chloroamphetamine","volume":"5","author":"Burish","year":"2015","journal-title":"Neurohospital"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0095","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0100","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1177\/0269881118754710","article-title":"Psychedelics and the essential importance of context","volume":"32","author":"Carhart-Harris","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0105","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1177\/02698811211021588","article-title":"Recreational ketamine-related deaths notified to the National Programme on substance abuse deaths, England, 1997\u20132019","volume":"35","author":"Corkery","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0110","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/02698811211026645","article-title":"Deaths from novel psychoactive substances in England, Wales and Northern Ireland: evaluating the impact of the UK psychoactive substances act 2016","volume":"35","author":"Deen","year":"2021","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0115","article-title":"New-onset seizures in an adolescent following use of LSD while on low-dose Lithium therapy: a case study","volume":"77","author":"Edwards","year":"2024","journal-title":"S. D. Med."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0293349","article-title":"Extended difficulties following the use of psychedelic drugs: a mixed methods study","volume":"18","author":"Evans","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0125","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1360-0443.2004.00744.x","article-title":"Comparison of acute lethal toxicity of commonly abused psychoactive substances","volume":"99","author":"Gable","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0130","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/add.16432","article-title":"Trends in hallucinogen-associated emergency department visits and hospitalizations in California, USA, from 2016 to 2022","volume":"119","author":"Garel","year":"2024","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0135","first-page":"1","article-title":"Fatal poisoning after a group of people voluntarily consumed hallucinogenic mushrooms","volume":"112","author":"Gerault","year":"1996","journal-title":"Le Bull. Soc. Mycolog. France"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0140","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/02791072.2022.2028203","article-title":"A systematized review of drug-checking and related considerations for implementation as a harm reduction intervention","volume":"55","author":"Giulini","year":"2023","journal-title":"J. Psychoactive Drugs"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0145","series-title":"GDS: The Highway Code","first-page":"2021","author":"Global Drug Survey","year":"2014"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0150","series-title":"Communal Psychedelic Integration: How Group Therapy Is Integral to Wholeness","author":"Gross","year":"2021"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0155","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1177\/02698811231179910","article-title":"Attenuation of psilocybin mushroom effects during and after SSRI\/SNRI antidepressant use","volume":"37","author":"Gukasyan","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0160","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/add.13941","article-title":"The future of the international drug control system and national drug prohibitions","volume":"113","author":"Hall","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0165","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pharmthera.2017.10.022","article-title":"Effect fingerprinting of new psychoactive substances (NPS): what can we learn from in vitro data?","volume":"182","author":"Hondebrink","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0170","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1111\/1556-4029.13982","article-title":"Unpredictable behavior under the influence of \u201cmagic mushrooms\u201d: a case report and review of the literature","volume":"64","author":"Honyiglo","year":"2019","journal-title":"J. Forensic Sci."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0175","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/0269881108093587","article-title":"Human hallucinogen research: guidelines for safety","volume":"22","author":"Johnson","year":"2008","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0180","first-page":"114","article-title":"Day trip to hell: a mixed methods study of challenging psychedelic experiences","volume":"5","author":"Johnstad","year":"2021","journal-title":"J. Psych. Stud."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0185","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1111\/bcp.15352","article-title":"Fatalities associated with gabapentinoids in England (2004\u20132020)","volume":"88","author":"Kalk","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0190","first-page":"183","article-title":"Coma, hyperthermia and bleeding associated with massive LSD overdose: a report of eight cases","volume":"120","author":"Klock","year":"1974","journal-title":"West. J. Med."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0195","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/02698811221099650","article-title":"Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)","volume":"36","author":"Kopra","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0200","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/02698811221084063","article-title":"Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms","volume":"36","author":"Kopra","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0205","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1177\/02698811231158245","article-title":"Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: findings from the global drug survey 2020","volume":"37","author":"Kopra","year":"2023","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.psycr.2023.100118","article-title":"A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history","volume":"2","author":"Kramer","year":"2023","journal-title":"Psychiatry Res. Case Reports"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0215","first-page":"1","article-title":"Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey","author":"Kuc","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000020868","article-title":"Self-inflicted neck wounds under influence of lysergic acid diethylamide: a case report and literature review","volume":"99","author":"Le Dare","year":"2020","journal-title":"Medicine"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283549","article-title":"Opioid-related deaths during hospital admissions or shortly after discharge in the United Kingdom: a thematic framework analysis of coroner reports","volume":"18","author":"Lewer","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0230","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1111\/j.1445-5994.2012.02955.x","article-title":"A fatal case of \u2018magic mushroom\u2019ingestion in a heart transplant recipient","volume":"11","author":"Lim","year":"2012","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0235","series-title":"Jim Harris Was Paralyzed. Then He Ate Magic Mushrooms","first-page":"2024","author":"Mabe","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0240","first-page":"1","article-title":"Serotonin toxicity of serotonergic psychedelics","author":"Malcolm","year":"2021","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0245","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.118.543.229","article-title":"Acute adverse reactions to LSD in clinical and experimental use in the United Kingdom","volume":"118","author":"Malleson","year":"1971","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0250","series-title":"MAPS Provides Psychedelic Crisis Assessment and Intervention Training to Denver\u2019s First Responders","author":"MAPS","year":"2024"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109399","article-title":"The varieties of psychedelic law","volume":"226","author":"Marks","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0260","series-title":"Psychiatric Risks for Worsened Mental Health After Psychedelic Use","author":"Marrocu","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0265","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3390\/ph16081158","article-title":"Unraveling the in vitro toxicity profile of psychedelic 2C phenethylamines and their N-Benzylphenethylamine (NBOMe) analogues","volume":"16","author":"Martins","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0270","first-page":"2024","article-title":"Integrating psychedelics and paralysis: understanding non-obvious risks before pursuing likely rewards","author":"McMillan","year":"2024","journal-title":"Intercolleg. Psyched. Network"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0275","first-page":"2024","article-title":"Off-duty pilot accused of trying to shut off airliner\u2019s engines mid-flight said he took \u2018magic mushrooms\u2019 48 hours before the incident, court documents say","author":"Muntean","year":"2023","journal-title":"CNN"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0280","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1177\/00048674221081763","article-title":"The challenges ahead for psychedelic \u2018medicine\u2019. Austral","volume":"56","author":"Muthukumaraswamy","year":"2022","journal-title":"New Zeal. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0285","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1055\/a-1524-2794","article-title":"Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports","volume":"54","author":"Nayak","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0290","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.forsciint.2018.01.006","article-title":"Is LSD toxic?","volume":"284","author":"Nichols","year":"2018","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0295","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1111\/bcp.14819","article-title":"Antihistamine-related deaths in England: are the high safety profiles of antihistamines leading to their unsafe use?","volume":"87","author":"Oyekan","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0300","doi-asserted-by":"crossref","DOI":"10.1002\/hup.2719","article-title":"A qualitative descriptive analysis of effects of psychedelic phenethylamines and tryptamines","volume":"35","author":"Palamar","year":"2020","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0305","series-title":"Are You Tripping Comfortably? Investigating the Relationship Between Harm Reduction and the Psychedelic Experience","author":"Palmer","year":"2022"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0310","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/jamapsychiatry.2021.3972","article-title":"The rapid rise in investment in psychedelics\u2014cart before the horse","volume":"79","author":"Phelps","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-021-00489-1","article-title":"Ethical and legal issues in psychedelic harm reduction and integration therapy","volume":"18","author":"Pilecki","year":"2021","journal-title":"Harm Reduct. J."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0320","series-title":"Reducing the Harms of Nonclinical Psychedelics Use through a Peer-Support Telephone Helpline","author":"Pleet","year":"2023"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0325","doi-asserted-by":"crossref","first-page":"170934","DOI":"10.1016\/j.scitotenv.2024.170934","article-title":"Characterising differences between self-reported and wastewater-identified drug use at two consecutive years of an Australian music festival","volume":"921","author":"Puljevi\u0107","year":"2024","journal-title":"Sci. Total Environ."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0330","series-title":"Coming Back Together: A Qualitative Survey Study of Coping and Support Strategies Used by People to Cope with Extended Difficulties after the Use of Psychedelic Drugs","author":"Robinson","year":"2024"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0335","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1177\/02698811221115760","article-title":"Can cannabis kill? Characteristics of deaths following cannabis use in England (1998\u20132020)","volume":"36","author":"Rock","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109376","article-title":"Highlighting the hidden dangers of a \u2018weak\u2019opioid: deaths following use of dihydrocodeine in England (2001\u22122020)","volume":"233","author":"Rock","year":"2022","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0345","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/jat\/bkad002","article-title":"From bumps to binges: overview of deaths associated with cocaine in England, Wales and Northern Ireland (2000\u20132019)","volume":"47","author":"Rooney","year":"2023","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0350","first-page":"1","article-title":"Strong bipartisan support for controlled psilocybin use as treatment or enhancement in a representative sample of US Americans: need for caution in public policy persists","author":"Sandbrink","year":"2024","journal-title":"AJOB Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0355","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0360","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jad.2023.01.073","article-title":"Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics","volume":"326","author":"Simonsson","year":"2023","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0365","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1001\/jama.2021.12481","article-title":"Two models of legalization of psychedelic substances: reasons for concern","volume":"326","author":"Smith","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.109165","article-title":"Novel ethical and policy issues in psychiatric uses of psychedelic substances","volume":"216","author":"Smith","year":"2022","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0375","first-page":"4","article-title":"Framework analysis: a qualitative methodology for applied policy research","author":"Srivastava","year":"2008","journal-title":"JOAAG"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0380","series-title":"Briton, 19, Died After Taking Hallucinogen in Colombia, Inquest Told","first-page":"2024","author":"The Guardian","year":"2018"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0385","series-title":"Drug Decriminalization Policy: Literature Review: Models, Implementation and Outcomes","author":"Unlu","year":"2020"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0390","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.yrtph.2011.01.006","article-title":"Harm potential of magic mushroom use: a review","volume":"59","author":"Van Amsterdam","year":"2011","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0395","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3390\/ijms25010241","article-title":"Molecular and medical aspects of psychedelics","volume":"25","author":"Wojtas","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0400","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamapsychiatry.2022.2546","article-title":"Preparing for the bursting of the psychedelic hype bubble","volume":"79","author":"Yaden","year":"2022","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111177_bb0405","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fnint.2018.00054","article-title":"The varieties of the psychedelic experience: a preliminary study of the association between the reported subjective effects and the binding affinity profiles of substituted phenethylamines and tryptamines","volume":"12","author":"Zamberlan","year":"2018","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0410","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.00078","article-title":"NBOMes\u2013highly potent and toxic alternatives of LSD","volume":"14","author":"Zawilska","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111177_bb0415","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/acsptsci.1c00024","article-title":"On the relationship between classic psychedelics and suicidality: a systematic review","volume":"4","author":"Zeifman","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584624002458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T11:05:29Z","timestamp":1745838329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584624002458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":83,"alternative-id":["S0278584624002458"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111177","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychedelic-related deaths in England, Wales and Northern Ireland (1997\u20132022)","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111177"}}